CUL4A and nasopharyngeal carcinoma: So, the data on CUL4A expression in tumor tissues to help identify patients who may or may not benefit from radiotherapy and chemotherapy, so as to design optimal, individualized treatment for NPC patients.[20] Furthermore, this study also indicates that CUL4A expression may influence the response of radiotherapy and chemotherapy in NPC patients.